Literature DB >> 16550751

Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease?

T H Westhoff1, R Waldherr, C Loddenkemper, W Ries, W Zidek, M van der Giet.   

Abstract

BACKGROUND: Mesangial deposition of IgA (MCA) is a very rare finding in minimal change disease and has previously been considered a pure coincidence. In the U.S. and Europe only anecdotal case reports exist. To date, there has been no consensus on nomenclature and categorization of this entity. We describe 2 cases of MCA with analogue histological findings but relevant differences in clinical presentation, and we discuss the clinical implications of mesangial IgA deposition in minimal change nephrotic syndrome. PATIENTS: A 47-year-old female was admitted to hospital with nephrotic syndrome, microscopic hematuria, arterial hypertension and slight impairment of renal function 3 weeks after an unspecific upper airway infection. A 42-year-old male presented with nephrotic syndrome, microscopic hematuria, normotension and normal renal function. Both of the nephrotic syndromes were steroid-responsive and steroid-dependent.
FINDINGS: The clinical presentation of the male patient was consistent with the features of minimal change glomerulopathy, whereas the female patient combined signs of minimal change disease and IgA nephropathy. Light microscopy revealed mesangial IgA immune deposits and slight mesangial hypercellularity. Electron microscopic studies of MCA patients disclose diffuse effacement of glomerular foot processes.
CONCLUSION: Our cases and a review of the literature indicate that the histological diagnosis of MCA may comprise different pathogenetic entities. From the clinical point of view, MCA has to be regarded as a minimal change nephrotic syndrome with symptomatic or asymptomatic mesangial IgA deposition. IgA deposition constitutes a risk factor for impairment of renal function and indicates a frequently relapsing course.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16550751     DOI: 10.5414/cnp65203

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  A case of IgA nephropathy with deep venous thrombosis in the mesentery and lower extremities.

Authors:  Hong Tang; Lei Zhang; Wei Zhao; Rongquan Chen; Min Xie
Journal:  Quant Imaging Med Surg       Date:  2018-12

2.  A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis.

Authors:  Misaki Hirose; Tomoya Nishino; Tadashi Uramatsu; Yoko Obata; Mineaki Kitamura; Tayo Kawazu; Masanobu Miyazaki; Takashi Taguchi; Shigeru Kohno
Journal:  Clin Exp Nephrol       Date:  2012-01-19       Impact factor: 2.801

3.  IgA nephropathy with minimal change disease.

Authors:  Leal C Herlitz; Andrew S Bomback; Michael B Stokes; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

4.  Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.

Authors:  Xiao-Wei Li; Shao-Shan Liang; Wei-Bo Le; Shui-Qin Cheng; Cai-Hong Zeng; Jin-Quan Wang; Zhi-Hong Liu
Journal:  J Nephrol       Date:  2015-11-04       Impact factor: 3.902

5.  Immune Characteristics of IgA Nephropathy With Minimal Change Disease.

Authors:  Huixian Li; Wanhong Lu; Haiyun Li; Xiaoling Liu; Xue Zhang; Liyi Xie; Ping Lan; Xiaoyang Yu; Yinjuan Dai; Xinfang Xie; Jicheng Lv
Journal:  Front Pharmacol       Date:  2021-12-16       Impact factor: 5.810

6.  Clinicopathologic characteristics of IgA nephropathy with steroid-responsive nephrotic syndrome.

Authors:  Sun Moon Kim; Kyung Chul Moon; Kook-Hwan Oh; Kwon Wook Joo; Yon Su Kim; Curie Ahn; Jin Suk Han; Suhnggwon Kim
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.